在儿童中使用糖尿病技术
Melissa J Schoelwer1, Mark D DeBoer1, Marc D Breton2
1Department of Pediatrics, University of Virginia, Charlottesville, VA, USA.
Diabetologia
|July 12, 2024
概括
新的糖尿病技术,包括连续血糖监测器和自动胰岛素输送系统,显著改善了1型糖尿病儿童的血糖控制和生活质量.
科学领域:
- 儿科内分泌学 儿科内分泌学
- 生物医学工程 生物医学工程
- 糖尿病管理技术 技术 糖尿病管理
背景情况:
- 1型糖尿病给儿童及其照顾者带来了重大日常管理挑战.
- 技术进步正在改变儿科糖尿病护理的格局.
- 传统方法往往涉及相当大的负担,影响生活质量.
研究的目的:
- 审查当前的糖尿病技术用于儿科1型糖尿病管理.
- 讨论持续血糖监测和自动化胰岛素输送系统的好处.
- 突出1型糖尿病儿童和青少年的独特管理考虑因素.
主要方法:
- 对儿科人口糖尿病技术的关键数据的综述.
- 与持续血糖监测 (CGM) 相关的结果分析.
- 对幼儿的自动化胰岛素输送系统 (AID) 的安全性和有效性数据的评估.
主要成果:
- 持续血糖监测 (CGM) 仅仅是提高结果,是标准的护理.
- 自动注射胰岛素 (AID) 系统对于2岁以下的儿童是安全有效的.
- 艾滋病辅助系统改善了儿科患者和护理人员的血糖控制和生活质量.
结论:
- 糖尿病技术,特别是CGM和AID,为患有1型糖尿病的儿童提供了巨大的好处.
- 应强烈考虑对所有符合条件的1型糖尿病青少年提供AID系统,如果可获得和负担得起.
- 技术整合减轻了糖尿病管理的负担,允许更严格的血糖控制,减少对低血糖的恐惧.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes: Management and Pharmacotherapy
256
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
256
Diabetes: Symptoms, Diagnosis, and Complications
521
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
521
Insulin: Dosing Regimen and Adverse Effects
165
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
165
Pathophysiology of Diabetes
917
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
917


